Shanghai MicroPort MedBot (Group) Co., Ltd. (HKG:2252)
15.94
-0.02 (-0.13%)
Jun 6, 2025, 4:08 PM HKT
HKG:2252 Revenue
In the year 2024, Shanghai MicroPort MedBot (Group) had annual revenue of 257.25M CNY with 145.95% growth. Shanghai MicroPort MedBot (Group) had revenue of 158.01M in the half year ending December 31, 2024, with 668.73% growth.
Revenue
257.25M CNY
Revenue Growth
+145.95%
P/S Ratio
59.67
Revenue / Employee
580.70K CNY
Employees
443
Market Cap
16.33B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines | 32.53B |
Hansoh Pharmaceutical Group Company | 13.05B |
JD Health International | 61.89B |
Innovent Biologics | 10.03B |
WuXi Biologics | 19.87B |
CSPC Pharmaceutical Group | 28.99B |
Sino Biopharmaceutical | 30.72B |
Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |